CEE Pharma and Healthcare Sector Report 2025-2026

The CEE pharmaceutical and healthcare sector demonstrates remarkable resilience amid regional economic pressures, with each country adopting distinct strategies to address similar challenges. The overall market continues its growth trajectory, though with varying intensities across the region, as governments balance fiscal constraints with increasing healthcare demands.

This report provides a complete and detailed analysis of the "Pharmaceuticals production" sector for Central and Eastern Europe. EMIS Insights presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

What this report allows you to do:

• Understand the key elements at play in the "Pharmaceuticals production" sector in Central and Eastern Europe
• Crystallise the forces both driving and restraining this sector in Central and Eastern Europe
• Ascertain Central and Eastern Europe’s position in the global sector
• Build a complete perspective on sector trade, investment and employment
• Understand the competitive landscape and who the major players are
• View M&A activity and major deals
• Gain an understanding of the regulatory environment for the sector in Central and Eastern Europe.
• Build a clear picture of trends, output and consumption for specific sub-sectors